|
1
|
Mannarino E and Pirro M: Molecular biology
of atherosclerosis. Clin Cases Miner Bone Metab. 5:57–62.
2008.PubMed/NCBI
|
|
2
|
Mitra S, Deshmukh A, Sachdeva R, Lu J and
Mehta JL: Oxidized low-density lipoprotein and atherosclerosis
implications in antioxidant therapy. Am J Med Sci. 342:135–142.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kolluru GK, Bir SC and Kevil CG:
Endothelial dysfunction and diabetes: effects on angiogenesis,
vascular remodeling, and wound healing. Int J Vasc Med. Feb
12–2012.(Epub ahead of print) doi: 10.1155/2012/918267. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mathieu P, Pibarot P and Després JP:
Metabolic syndrome: The danger signal in atherosclerosis. Vasc
Health Risk Manag. 2:285–302. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen CH, Jiang W, Via DP, Luo S, Li TR,
Lee YT and Henry PD: Oxidized low-density lipoproteins inhibit
endothelial cell proliferation by suppressing basic fibroblast
growth factor expression. Circulation. 101:171–177. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Inoue M, Itoh H, Tanaka T, Chun TH, Doi K,
Fukunaga Y, Sawada N, Yamshita J, Masatsugu K, Saito T, et al:
Oxidized LDL regulates vascular endothelial growth factor
expression in human macrophages and endothelial cells through
activation of peroxisome proliferator-activated receptor-gamma.
Arterioscler Thromb Vasc Biol. 21:560–566. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kuzuya M, Ramos MA, Kanda S, Koike T, Asai
T, Maeda K, Shitara K, Shibuya M and Iguchi A: VEGF protects
against oxidized LDL toxicity to endothelial cells by an
intracellular glutathione-dependent mechanism through the KDR
receptor. Arterioscler Thromb Vasc Biol. 21:765–770. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jovinge S, Ares MP, Kallin B and Nilsson
J: Human monocytes/macrophages release TNF-alpha in response to
Ox-LDL. Arterioscler Thromb Vasc Biol. 16:1573–1579. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Erl W, Weber PC and Weber C: Monocytic
cell adhesion to endothelial cells stimulated by oxidized low
density lipoprotein is mediated by distinct endothelial ligands.
Atherosclerosis. 136:297–303. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Antoniades C, Demosthenous M, Tousoulis D,
Antonopoulos AS, Vlachopoulos C, Toutouza M, Marinou K, Bakogiannis
C, Mavragani K, Lazaros G, et al: Role of asymmetrical
dimethylarginine in inflammation-induced endothelial dysfunction in
human atherosclerosis. Hypertension. 58:93–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thorin-Trescases N, Voghel G, Gendron ME,
Krummen S, Farhat N, Drouin A, Perrault LP and Thorin E:
Pathological aging of the vascular endothelium: Are endothelial
progenitor cells the sentinels of the cardiovascular system? Can J
Cardiol. 21:1019–1024. 2005.PubMed/NCBI
|
|
12
|
Chen YH, Lin SJ, Chen YL, Liu PL and Chen
JW: Anti-inflammatory effects of different drugs/agents with
antioxidant property on endothelial expression of adhesion
molecules. Cardiovasc Hematol Disord Drug Targets. 6:279–304. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Alcaide P, Liu L, Sun J, He A,
Luscinskas FW and Shi GP: Regulation of endothelial cell adhesion
molecule expression by mast cells, macrophages, and neutrophils.
PLoS One. 6:e145252011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chi Z and Melendez AJ: Role of cell
adhesion molecules and immune-cell migration in the initiation,
onset and development of atherosclerosis. Cell Adh Migr. 1:171–175.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koch S and Claesson-Welsh L: Signal
transduction by vascular endothelial growth factor receptors. Cold
Spring Harb Perspect Med. 2:a0065022012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goel HL and Mercurio AM: VEGF targets the
tumour cell. Nat Rev Cancer. 13:871–882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gerhardt H, Golding M, Fruttiger M,
Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C,
Alitalo K, Shima D and Betsholtz C: VEGF guides angiogenic
sprouting utilizing endothelial tip cell filopodia. J Cell Biol.
161:1163–1177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen B, Zhao J, Zhang S, Wu W and Qi R:
Aspirin inhibits the production of reactive oxygen species by
downregulating Nox4 and inducible nitric oxide synthase in human
endothelial cells exposed to oxidized low-density lipoprotein. J
Cardiovasc Pharmacol. 59:405–412. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pirillo A, Norata GD and Catapano AL:
LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm. Jul
10–2013.(Epub ahead of print) doi: 10.1155/2013/152786. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Henry TD, Annex BH, McKendall GR, Azrin
MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman
DS, et al: VIVA Investigators: The VIVA trial: Vascular endothelial
growth factor in Ischemia for Vascular Angiogenesis. Circulation.
107:1359–1365. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mäkinen K, Manninen H, Hedman M, Matsi P,
Mussalo H, Alhava E and Ylä-Herttuala S: Increased vascularity
detected by digital subtraction angiography after VEGF gene
transfer to human lower limb artery: A randomized,
placebo-controlled, double-blinded phase II study. Mol Ther.
6:127–133. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hedman M, Hartikainen J, Syvänne M,
Stjernvall J, Hedman A, Kivelä A, Vanninen E, Mussalo H, Kauppila
E, Simula S, et al: Safety and feasibility of catheter-based local
intracoronary vascular endothelial growth factor gene transfer in
the prevention of postangioplasty and in-stent restenosis and in
the treatment of chronic myocardial ischemia: Phase II results of
the Kuopio Angiogenesis Trial (KAT). Circulation. 107:2677–2683.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rajagopalan S, Mohler ER III, Lederman RJ,
Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler
PD, Rasmussen HS and Annex BH: Regional angiogenesis with vascular
endothelial growth factor in peripheral arterial disease: A phase
II randomized, double-blind, controlled study of adenoviral
delivery of vascular endothelial growth factor 121 in patients with
disabling intermittent claudication. Circulation. 108:1933–1938.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kukuła K, Chojnowska L, Dąbrowski M,
Witkowski A, Chmielak Z, Skwarek M, Kądziela J, Teresińska A,
Małecki M, Janik P, et al: Intramyocardial plasmid-encoding human
vascular endothelial growth factor A165/basic fibroblast growth
factor therapy using percutaneous transcatheter approach in
patients with refractory coronary artery disease (VIF-CAD). Am
Heart J. 161:581–589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kastrup J, Jørgensen E, Rück A, Tägil K,
Glogar D, Ruzyllo W, Bøtker HE, Dudek D, Drvota V, Hesse B, et al:
Euroinject One Group: Direct intramyocardial plasmid vascular
endothelial growth factor-A165 gene therapy in patients with stable
severe angina pectoris A randomized double-blind placebo-controlled
study: The Euroinject One trial. J Am Coll Cardiol. 45:982–988.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duan J, Murohara T, Ikeda H, Katoh A,
Shintani S, Sasaki K, Kawata H, Yamamoto N and Imaizumi T:
Hypercholesterolemia inhibits angiogenesis in response to hindlimb
ischemia: Nitric oxide-dependent mechanism. Circulation. 102:(Suppl
3). III370–III376. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matter CM, Ma L, von Lukowicz T, Meier P,
Lohmann C, Zhang D, Kilic U, Hofmann E, Ha SW, Hersberger M, et al:
Increased balloon-induced inflammation, proliferation, and
neointima formation in apolipoprotein E (ApoE) knockout mice.
Stroke. 37:2625–2632. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Osto E, Matter CM, Kouroedov A, Malinski
T, Bachschmid M, Camici GG, Kilic U, Stallmach T, Boren J, Iliceto
S, et al: c-Jun N-terminal kinase 2 deficiency protects against
hypercholesterolemia-induced endothelial dysfunction and oxidative
stress. Circulation. 118:2073–2080. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
ElAli A, Doeppner TR, Zechariah A and
Hermann DM: Increased blood-brain barrier permeability and brain
edema after focal cerebral ischemia induced by hyperlipidemia: Role
of lipid peroxidation and calpain-1/2, matrix
metalloproteinase-2/9, and RhoA overactivation. Stroke.
42:3238–3244. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Du F, Zhou J, Gong R, Huang X, Pansuria M,
Virtue A, Li X, Wang H and Yang XF: Endothelial progenitor cells in
atherosclerosis. Front Biosci (Landmark Ed). 17:2327–2349. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang PY, Luo S, Jiang T, Lee YT, Lu SC,
Henry PD and Chen CH: Oxidized low-density lipoprotein
downregulates endothelial basic fibroblast growth factor through a
pertussis toxin-sensitive G-protein pathway: Mediator role of
platelet-activating factor-like phospholipids. Circulation.
104:588–593. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chavakis E, Dernbach E, Hermann C, Mondorf
UF, Zeiher AM and Dimmeler S: Oxidized LDL inhibits vascular
endothelial growth factor-induced endothelial cell migration by an
inhibitory effect on the Akt/endothelial nitric oxide synthase
pathway. Circulation. 103:2102–2107. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Salomonsson L, Svensson L, Pettersson S,
Wiklund O and Ohlsson BG: Oxidised LDL decreases VEGFR-1 expression
in human monocyte-derived macrophages. Atherosclerosis.
169:259–267. 2003. View Article : Google Scholar : PubMed/NCBI
|
